Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Operating activities:
Net income	$ 182,853	$ 87,358
Income from discontinued operations	(4,638)	(245)
Income from continuing operations	178,215	87,113
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	31,181	19,405
Amortization and impairments to operating lease assets	25,330	24,705
Depreciation	30,267	29,879
Amortization of acquired intangible assets	8,415	28,296
Amortization of debt discount and issuance costs	4,995	4,550
Provision for bad debts	46,854	35,741
Deferred income taxes	19,994	(4,650)
Loss on disposals and impairments of property and equipment	2,522	50
Gain on investments	(268)	(1,281)
Unrealized loss on assets held for sale		647
Changes in assets and liabilities:
Accounts and financing receivables	(80,613)	(73,661)
Prepaid expenses and other current assets	5,727	(2,484)
Cloud computing implementation assets	(21,959)	(19,262)
Accounts payable	(9,978)	12,632
Accrued payroll and benefits	1,406	15,671
Accrued liabilities	(10,449)	39,748
Deferred revenue	66,081	60,935
Operating lease liabilities	(17,839)	(28,448)
Other assets and liabilities	(6,068)	(2,475)
Net cash provided by operating activities-continuing operations	273,813	227,111
Net cash provided by operating activities-discontinued operations	4,394	8,396
Net cash provided by operating activities	278,207	235,507
Investing activities:
Capital expenditures	(31,337)	(32,316)
Proceeds from sales of marketable securities	3,120	626
Purchases of marketable securities	(2,048)	(498)
Net cash used in investing activities	(30,265)	(32,188)
Financing activities:
Proceeds from exercise of stock options	10,008	15,412
Employee taxes paid on withholding shares	(12,457)	(6,600)
Proceeds from stock issued under Colleague Stock Purchase Plan	922	581
Repurchases of common stock for treasury	(146,436)	(250,463)
Proceeds from issuance of long-term debt	9,873	1,896
Repayments of long-term debt	(109,873)	(51,896)
Net cash used in financing activities	(247,963)	(291,070)
Net decrease in cash, cash equivalents and restricted cash	(21)	(87,751)
Cash, cash equivalents and restricted cash at beginning of period	221,202	275,075
Cash, cash equivalents and restricted cash at end of period	221,181	187,324
Non-cash investing and financing activities:
Accrued capital expenditures	12,410	6,217
Accrued liability for repurchases of common stock	4,879	2,995
Accrued excise tax on share repurchases	$ 1,055	$ 3,257